← Leaderboards
Ashok K Chopra
University Of Texas Medical Br Galveston
$11,194,492
Attributed
$13,854,727
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,854,727 · 9
By mechanism
R01$7,998,683 · 3
R44$2,923,479 · 1
T32$1,192,258 · 1
R21$932,936 · 2
R56$807,371 · 2
Top collaborators
- Scott C Weaver7 shared
- Krishna Rajarathnam3 shared
- Eric Rothe3 shared
- Janice J Endsley2 shared
- Sara M Dann1 shared
Most similar at University Of Texas Medical Br Galveston
Same institution · by research overlap
- Randall M Goldblum$2,367,141
Others in their field
Top investigators on “Immunity”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmunityMouse ModelInfectionBacteriaImmune ResponseResponseVirulencePneumonic PlagueAntibiotic ResistanceYersinia PestisVaccinesAttenuatedGenesPlague VaccinePlagueAntigensAnimalsGenerationsBaseMutantVaccine CandidateLipoproteinsPathogenSerum
Grant awards (39)
Immunological characterization of rationally-designed vaccines against plague in mice and non-human primate models$621,983
R01 · FY2025 · AI · contact PI
Biodefense Training Program$193,604
T32 · FY2025 · AI · contact PI
Immunological characterization of rationally-designed vaccines against plague in mice and non-human primate models$757,093
R01 · FY2024 · AI · contact PI
Biodefense Training Program$175,294
T32 · FY2024 · AI · contact PI
Biodefense Training Program$165,520
T32 · FY2023 · AI · contact PI
Immunological characterization of rationally-designed vaccines against plague in mice and non-human primate models$155,496
R01 · FY2023 · AI · contact PI
Immunological characterization of rationally-designed vaccines against plague in mice and non-human primate models$695,461
R01 · FY2022 · AI · contact PI
Biodefense Training Program$178,827
T32 · FY2022 · AI · contact PI
Immunological characterization of rationally-designed vaccines against plague in mice and non-human primate models$574,886
R01 · FY2021 · AI · contact PI
Immunological characterization of rationally-designed vaccines against plague in mice and non-human primate models$277,816
R01 · FY2021 · AI · contact PI
Biodefense Training Program$159,634
T32 · FY2021 · AI · contact PI
Immunological characterization of rationally-designed vaccines against plague in mice and non-human primate models$224,539
R56 · FY2020 · AI · contact PI
Biodefense Training Program$157,902
T32 · FY2020 · AI · contact PI
Engineered chemokines as therapeutics for bacterial infections$197,500
R21 · FY2019 · AI
Underlying mechanisms of necrotizing fasciitis during polymicrobial infections$197,500
R21 · FY2019 · AI · contact PI
Biodefense Training Program$161,477
T32 · FY2019 · AI · contact PI
Engineered chemokines as therapeutics for bacterial infections$65,436
R21 · FY2019 · AI
FDA approved non-antibiotic drugs to combat multiple drug resistant microbes$582,832
R56 · FY2018 · AI · contact PI
Underlying mechanisms of necrotizing fasciitis during polymicrobial infections$236,500
R21 · FY2018 · AI · contact PI
Engineered chemokines as therapeutics for bacterial infections$236,000
R21 · FY2018 · AI
Identification of new antigens for a plague vaccine$339,304
R01 · FY2015 · AI · contact PI
Evaluation and Production of a Multivalent Adenoviral Plague Vaccine$951,043
R44 · FY2014 · AI
Identification of new antigens for a plague vaccine$339,304
R01 · FY2014 · AI · contact PI
Evaluation and Production of a Multivalent Adenoviral Plague Vaccine$976,943
R44 · FY2013 · AI
Identification of new antigens for a plague vaccine$321,940
R01 · FY2013 · AI · contact PI
Evaluation and Production of a Multivalent Adenoviral Plague Vaccine$995,493
R44 · FY2012 · AI
Identification of new antigens for a plague vaccine$344,337
R01 · FY2012 · AI · contact PI
Identification of new antigens for a plague vaccine$344,337
R01 · FY2011 · AI · contact PI
Identification of New Antigens for a Plague Vaccine$272,881
R01 · FY2010 · AI · contact PI
Identification of New Antigens for a Plague Vaccine$422,557
R01 · FY2009 · AI · contact PI
Identification of New Antigens for a Plague Vaccine$351,137
R01 · FY2008 · AI · contact PI
Identification of New Antigens for a Plague Vaccine$357,938
R01 · FY2007 · AI · contact PI
Identification of New Antigens for a Plague Vaccine$368,629
R01 · FY2006 · AI · contact PI
Cytotoxic Enterotoxin in Aeromonas-mediated Diseases$221,177
R01 · FY2006 · AI · contact PI
Identification of New Antigens for a Plague Vaccine$377,500
R01 · FY2005 · AI
Cytotoxic Enterotoxin in Aeromonas-mediated Diseases$226,500
R01 · FY2005 · AI
Cytotoxic Enterotoxin in Aeromonas-mediated Diseases$226,500
R01 · FY2004 · AI
Cytotoxic Enterotoxin in Aeromonas-mediated Diseases$226,500
R01 · FY2003 · AI
CYTOLYTIC ENTEROTOXIN OF AEROMONAS HYDROPHILA$175,407
R01 · FY2000 · AI